Page last updated: 2024-09-04

pomalidomide and dinoprostone

pomalidomide has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
62312155229,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, RS; Haley, M; Muller, GW; Payvandi, F; Schafer, PH; Stirling, DI; Wu, L; Zhang, LH1

Other Studies

1 other study(ies) available for pomalidomide and dinoprostone

ArticleYear
Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.
    Cellular immunology, 2004, Volume: 230, Issue:2

    Topics: Blotting, Northern; Blotting, Western; Cyclooxygenase 2; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Factors; Interleukin-10; Isoenzymes; Lenalidomide; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Lymphotoxin-alpha; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; RNA; Thalidomide; Tumor Necrosis Factor-alpha

2004